Main Article Content
Abstract
Mergers and acquisitions (M&A) have become a globally acknowledged phenomenon. To gain the competitive advantage and increase in profit the companies take the path to enter into business with other companies either by selling off the unprofitable divisions or by acquiring assets like technology, skilled workforce, etc. In the past few years, there has been an evident rise in number and capital investment in M&A deals across all over the world including India. The financial stability, R&D expertise and access to innovations of the merged units have remained the major economic rationale behind M&A in the pharmaceutical industry. The broadness and complexity of this field has attracted research scholars to undertake different empirical studies and to review the M&A deals in different sectors including pharmaceutical sector in Indian scenario. This paper is based on a systematic review utilizing a structured approach to reviewing published academic research.